The heme oxygenase system and type-1 diabetes

Area of Science:

• Endocrinology and Metabolism
• Immunology
• Cell Biology

Background:

• Type-1 diabetes involves autoimmune destruction of pancreatic beta cells, leading to insulin deficiency and complications like oxidative stress and apoptosis.
• Both type-1 and type-2 diabetes can exhibit insulin deficiency and resistance, suggesting a need for revised nomenclature.
• The heme-oxygenase (HO) system and its byproducts (carbon monoxide, ferritin, biliverdin) are known to modulate immune/inflammatory responses, oxidative stress, and apoptosis.

Purpose of the Study:

• To review the role of the heme-oxygenase (HO) system and its products in type-1 diabetes pathogenesis.
• To highlight the potential of HO-system modulation for treating type-1 diabetes and its cardiometabolic complications.

Main Methods:

• Literature review focusing on the heme-oxygenase (HO) system, carbon monoxide, bilirubin, and their effects on pancreatic beta cells, immune responses, oxidative stress, and apoptosis in diabetes models.

Main Results:

• Upregulation of the HO-system enhances pancreatic beta-cell insulin release and reduces hyperglycemia in diabetic models.
• Carbon monoxide, a heme-oxygenase byproduct, improves glucose metabolism and insulin production.
• The HO-system's anti-inflammatory and anti-apoptotic properties are beneficial in type-1 diabetes.

Conclusions:

• The heme-oxygenase (HO) system and its products represent a promising therapeutic target for type-1 diabetes.
• Modulating the HO-system may offer a novel strategy to manage type-1 diabetes and associated cardiometabolic complications by targeting key pathophysiological pathways.